Corona Remedies to hold investor meetings in Singapore on June 8

1 min read Updated on 04 Jun 2026, 03:12 AM

Reviewed by

Ashish TScanX News Team

AI Summary

CORONA Remedies Limited announced it will conduct a Non-Deal Roadshow with 1x1 investor meetings in Singapore on June 8 and June 9, 2026, starting at 09:00 A.M. (SST). Organized by IIFL Capital, the discussions will rely solely on publicly available information without sharing any unpublished price sensitive information (UPSI). The regulatory filing, submitted on June 3, 2026, under Regulation 30 of the SEBI Listing Obligations Regulations, notes that the schedule is subject to change due to exigencies.

*this image is generated using AI for illustrative purposes only.

CORONA Remedies Limited will hold a series of investor meetings in Singapore on June 8 and June 9, 2026, as part of a Non-Deal Roadshow (NDR). The meetings, scheduled to begin at 09:00 A.M. (SST), are organized by IIFL Capital and will involve 1x1 interactions with investors. The company disclosed this schedule in a regulatory filing submitted on June 3, 2026.

The discussions during these meetings will be strictly based on publicly available information. The company confirmed that no unpublished price sensitive information (UPSI) will be shared during the interactions. This initiative is part of the company's ongoing engagement with the investment community.

The schedule for the meetings is detailed below:

Date and Time	Organized by	Nature of Meeting	Place
June 08, 2026 and June 09, 2026 09:00 A.M. (SST) Onwards	IIFL Capital	1x1 Meeting	Singapore

The filing was submitted pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company noted that changes to the schedule may occur due to exigencies on the part of the host or the company.

Chetna Prabhat Kumar Dharajiya, Company Secretary and Compliance Officer, signed the intimation on behalf of CORONA Remedies Limited. The information is also available on the company's official website.

Historical Stock Returns for Corona Remedies

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.10%	+1.56%	-1.47%	+18.28%	+18.28%	+18.28%

What strategic priorities is CORONA Remedies likely to emphasize during these investor meetings?

How might the outcomes of these meetings influence the company's future investor engagement strategies?

Could this roadshow signal potential upcoming capital raising activities or partnerships?

Read Next Article

CORONA Remedies to hold investor meetings on June 4

0 min read Updated on 02 Jun 2026, 05:15 AM

Reviewed by

Suketu GScanX News Team

Add as a preferred
source on Google

AI Summary

CORONA Remedies Limited has scheduled investor meetings in Mumbai on June 4 and June 5, 2026, as part of a Non-Deal Roadshow organized by JM Financial. The meetings will adhere to Regulation 30 of SEBI regulations, focusing on publicly available information without disclosing unpublished price sensitive information (UPSI). The schedule is subject to change due to exigencies.

*this image is generated using AI for illustrative purposes only.

CORONA Remedies Limited has scheduled a series of investor meetings as part of a Non-Deal Roadshow (NDR) on June 4 and June 5, 2026. The meetings, organized by JM Financial, will provide an opportunity for investors to engage with company officials in Mumbai. The discussions will focus on publicly available information, ensuring no unpublished price sensitive information (UPSI) is disclosed during the sessions.

The regulatory disclosure was made pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company noted that the schedule is subject to change due to exigencies on the part of the host or the company.

The following table outlines the schedule for the investor meetings: